A phase Ib study of vosaroxin, an anticancer quinolone derivative, in patients with relapsed or refractory acute leukemia

2011

A phase Ib study of vosaroxin, an anticancer quinolone derivative, in patients with relapsed or refractory acute leukemia

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

27

References

39

Citations